Open access peer-reviewed chapter

Introductory Chapter: Short Insight in Synthesis and Applications of Benzimidazole and Its Derivatives

Written By

Maria Marinescu

Reviewed: May 31st, 2019 Published: October 2nd, 2019

DOI: 10.5772/intechopen.87174

Chapter metrics overview

994 Chapter Downloads

View Full Metrics

1. Introduction

Benzimidazole is well known as an important pharmacophore among heterocyclic compounds due to the remarkable medicinal and pharmacological properties of its derivatives [1, 2, 3]. Among these currently marketed benzimidazole drugs to treat several diseases, we can mention bendamustine, selumetinib, galeterone, and pracinostat as antitumor agents; pantoprazole, lansoprazole, esomeprazole, and ilaprazole as proton pump inhibitors; bezitramide as an analgesic; mebendazole, albendazole, thiabendazole, and flubendazole as antihelminthics; ridinilazole as antibacterial; astemizole and bilastine as antihistamines; enviradine, samatasvir, and maribavir as antivirals; and candesartan and mibefradil as antihypertensive [1, 4, 5, 6, 7]. Recent research recommends benzimidazole derivatives as potential EGFR and erbB2 inhibitors [8, 9], DNA/RNA binding ligands [10, 11], antitumor agents [12, 13, 14], anti-Alzheimer agents [15, 16], antidiabetic agents [17, 18], antiparasitic agents [10, 19], antimicrobial agents [20, 21], antiquorum-sensing agents [12], and antimalarial agents [19]. Intensive studies have demonstrated the use of the benzimidazole scaffold as key pharmacophore in clinically approved analgesic and anti-inflammatory agents [22]. Chiral benzimidazole derivatives were found to be NaV1.8 (voltage-gated sodium channels) blockers, which play a key role in the transmission of pain signals, with excellent preclinical in vitro ADME and safety profile [23]. Other benzimidazole derivatives have been shown to be anti-HIV-1 agents through the protection of APOBEC3G protein [24]. Benzimidazoles grafted with aromatic nuclei have been noted as antioxidant agents [25]. A correlation of the grafted organic functions on the benzimidazole scaffold has been found with their therapeutic potential [26]. Thus, carboxylic acids, carbamates, and amidines have been shown to be effective anticancer drugs [26, 27, 28], benzimidazole esters were reported as antifungal agents [29], and 2-aminobenzimidazole derivatives possesses very good antimicrobial activity [30].

Structure-activity relationship (SAR) studies have shown that 1,2,5,6-substituted benzimidazoles with various substituents are analgesic and anti-inflammatory agents [22]. Also, SAR studies were accomplished for antiviral, anticancer, antihelminthic, antimicrobial, antimycobacterial, antidiabetic, antiprotozoal, antipsychotic, antidepressant, and antioxidant benzimidazole derivatives [1, 31, 32, 33].

Advertisement

2. Synthesis of the benzimidazole derivatives

Benzimidazole synthesis reported by Hoebrecker in 1872 has greatly improved and diversified over last decades precisely because of its very diverse applications which will be discussed in the third part of this chapter. Classical synthesis was improved in terms of reaction conditions: catalysts, solvents or solvent-free, heating source, microwaves or ultrasound, and of course, nonpollutant or ‘green’ conditions. In the following, we will make (1) a very short presentation of classical syntheses and (2) an introduction to benzimidazole syntheses by rearrangement reactions.

2.1 Classical syntheses of benzimidazoles

Synthesis methods of the benzimidazoles have been extensively summarized in previous studies, published by Wright [34] and Preston [35]. Actually, all classical syntheses of benzimidazoles represent modifications to two of the classic reactions [26]: (i) the Phillips-Ladenburg reaction, coupling 1,2-diaminobenzenes with carboxylic acids (see Figure 1) and (ii) Weitenhagen reaction, coupling of 1,2-diaminobenzenes with aldehydes and ketones (pathway 3) viabenzimidazoline 3. In the case of the Phillips-Ladenburg reaction, esters, acid anhydrides, acid chlorides, and lactones (pathway 1) can be used instead of the acids, and benzimidazoles were generated viaamide 1cyclization or amides, nitriles, amidines, guanidines and benzimidazoles were resulted viacyclization of amidine 2(pathway 2). The Phillips synthesis of benzimidazoles uses 4 N hydrochloric acid or glacial acetic acid, but various methods applied today use sulfuric acid or polyphosphoric acid. Reaction temperatures are high, reaching 250–300°C.

Figure 1.

Classical methods for synthesis of benzimidazoles.

2.2 Synthesis of benzimidazoles viarearrangement of quinoxalinones

The limitations of classical synthesis, especially with respect to the synthesis of heterocyclic substituted benzimidazoles, have led to other methods [36]. Rearrangements of quinoxalinones represent the most advantageous methods of synthesis currently reported [26, 36]. Hereinafter, some newer syntheses of benzimidazole derivatives are presented by quinoxalinone rearrangements. These new syntheses represent a combination of rearrangements, multicomponent reactions, and tandem sequences [26].

Thus, synthesis of benzimidazoles by the Hinsberg reaction implies condensation between 1,2-diaminobenzene and quinoxalin-2-one 4to afford 2-benzimidazolylquinoxaline 5in a 97% yield (see Figure 2). 2-(Indolizinyl)benzimidazoles 6were obtained in high yields using a Chichibabin reaction, by refluxing quinoxalin-2-one 4with α-picoline [37].

Figure 2.

Synthesis of 2-heteroaryl benzimidazoles by rearranging the quinoxalinones.

2-(Pyrol-3-yl)benzimidazole 7was synthesized by a Knorr reaction between α-aminoketone of quinoxalinone 4and ethyl acetoacetate [37].

Reaction of phenylhydrazine with 3-arylacylidene-3,4-dihydroquinoxalin-2(1H)-one 8in boiling acetic acid implies the formation of spiro-compound 9, which rearranges into pyrazolylbenzimidazole 10(see Figure 3) [26].

Figure 3.

Synthesis of 2-(1,5-diphenyl-1H-pyrazol-3-yl)-1H-benzo[d]imidazole10.

Advertisement

3. Applications of benzimidazole derivatives in other fields than medicinal and pharmaceutical chemistry

There are a large number of published scientific papers that refer to the synthesis, properties, and applications of benzimidazoles. Thus, if we search the keyword “benzimidazole” on Science Direct, we get 26,386 results, of which 915 are published in the last 4 months.

Particular attention has been paid to improving the synthesis of chiral benzimidazoles, a relatively young branch of chiral chemistry, due to their importance in the field of therapeutic agents [38]. Also, chiral benzimidazoles were used as organocatalysts in Diels-Alder reaction, asymmetric aldol type reactions, asymmetric Michael addition, or enantioselective α-chlorination reactions as well as in palladium and rhodium benzimidazole complexes used as catalysts in Mizoroki-Heck [39] and Suzuki-Miyaura coupling reactions or in reduction reactions [40].

But recent research shows that benzimidazole scaffold is important not only for its therapeutic applications but also for its different uses in (nano) materials chemistry as optical chemical sensors [41], with special applications in medicine, environmental science, and chemical technology and has obvious advantage over other sensing devices, such as ease of operation and low cost (see Figure 4).

Figure 4.

Applications of benzimidazole derivatives.

Supramolecular assemblies with interesting properties and with a wide range of applications like adsorbent materials, thermostable polymers, nanocontainers for small molecules, or liquid crystals for electronic conduction make up another use of benzimidazole and its derivatives [42, 43, 44, 45].

Polybenzimidazole (PBI) derivatives: solid electrolyte for fuel cells [46], fibers [47], thin coatings [48], protective coatings for aerospace applications [49], or for the removal of uranium, thorium, and palladium from aqueous medium [50] are intensively studied in recent years. With an experience of 32 years, PBI Performance Products from Charlotte, North Carolina, is the leader in firefighter safety in Europe, USA, and the Middle East. PBI fabrics protect firefighters in a number of fire services, being renowned for their proven protection from heat and flame [51]. Another use of polybenzimidazoles is as PBI-based mixed matrix membranes with exceptional high water vapor permeability and selectivity [52].

In addition, the organic compounds are the most preferred for future photonic technology. Thus, several benzimidazoles with very good non-linear optic (NLO) properties, from very small molecules, such as 2-mercaptobenzimidazole, 2-phenyl benzimidazole, and 2-hydroxybenzimidazole [53], till molecules with more complicated structures [54], were studied.

Benomyl and carbendazim are recommended as benzimidazole fungicides having low toxicities in low doses and also are not carcinogenic, mutagenic, or teratogenic [55]. The literature shows the conditions of using common benzimidazole pesticides and reported the use of benzimidazoles as herbicides and insecticides [56].

More and more research is being reported on the use of benzimidazoles as corrosion inhibitors for various metals (Cu, Fe, and Zn) under acidic conditions [57, 58].

Other authors have shown that benzimidazole is a versatile and essential chromophore for organic dyes with photophysical, electrochemical, and photovoltaic properties due to the position of donors, acceptors, and π-linkers in the benzene ring [59]. A broad range of nuances in watercolor painting and electrophotographic developer toner has been made over three decades using benzimidazol-2-one derivatives, highly appreciated for their durability and light resistance [36]. Benzimidazole proved to be an essential core for organic light emitting devices (OLEDs) with superior phosphorescence, thermal properties, and morphological stabilities [60].

Advertisement

4. Conclusion

Benzimidazole occupies a central place in the class of heterocyclic compounds used in pharmaceutical and medicinal chemistry. The chemistry and applications of benzimidazole and its derivatives are in continuous development, especially in the last decades. In the coming years, we expect new synthesis strategies and more exciting applications to meet world market requirements.

Advertisement

Conflict of interest

There is no ‘conflict of interest’ in writing this chapter.

References

  1. 1. Bansal Y, Silakari O. The therapeutic journey of benzimidazoles: A review. European Journal of Medicinal Chemistry. 2012;20(21):6208-6236. DOI: 10.1016/j.bmc.2012.09.013
  2. 2. Akhtar W, Khan MF, Verma G, Shaquiquzzaman M, Rizvi MA, Mehdi SH, et al. Therapeutic evolution of benzimidazole derivatives in the last quinquennial period. European Journal of Medicinal Chemistry. 2017;126:705-753. DOI: 10.1016/j.ejmech.2016.12.010
  3. 3. Rajesakhar S, Maiti B, Balamurali MM, Chanda K. Synthesis and medicinal applications of benzimidazoles: An overview. Current Organic Synthesis. 2017;14(1):40-60. DOI: 10.2174/1570179413666160818151932
  4. 4. Njar VC, Brodie AM. Discovery and development of galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancer. Journal of Medicinal Chemistry. 2015;58(5):2077-2087. DOI: 10.1021/jm501239f
  5. 5. Moniruzzaman RS, Mahmud T. Quantum chemical and pharmacokinetic studies of some proton pump inhibitor drugs. American Journal of Biomedical Sciences & Research. 2019;2(1):3-8. DOI: 10.34297/AJBSR.2019.02.000562
  6. 6. Scholten WK, Christensen AE, Olesen AE, Drewes AM. Quantifying the adequacy of opioid analgesic consumption globally: An updated method and early findings. American Journal of Public Health (AJPH). 2019;109(1):52-57. DOI: 10.2105/AJPH.2018.304753
  7. 7. Tahlan S, Kumar S, Ramasamy K, Lim SM, Shah SAA, Mani V, et al. Design, synthesis and biological profile of heterocyclic benzimidazole analogues as prospective antimicrobial and antiproliferative agents. BMC Chemistry. 2019;13(50):1-15. DOI: 10.1186/s13065-019-0567-x
  8. 8. Celik I, Ayhan-Kilcigil G, Guven B, Kara Z, Gurkan AAS, Karayel A, et al. Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors. European Journal of Medicinal Chemistry. 2019;173:240-249. DOI: 10.1016/j.ejmech.2019.04.012
  9. 9. Akhtar MJ, Siddiqui AA, Khan AA, Ali Z, Dewangan RP, Pasha S, et al. Design, synthesis, docking and QSAR study of substituted benzimidazole linked oxadiazole as cytotoxic agents, EGFR and erbB2 receptor inhibitors. European Journal of Medicinal Chemistry. 2017;126:853-869. DOI: 10.1016/j.ejmech.2016.12.014
  10. 10. Popov AB, Stolic I, Krstulovic L, Taylor MC, Kelly JM, Tomic S, et al. Novel symmetric bis-benzimidazoles: Synthesis, DNA/RNA binding and antitrypanosomal activity. European Journal of Medicinal Chemistry. 2019;173:63-75. DOI: 10.1016/j.ejmech.2019.04.007
  11. 11. Ding Y, Chai J, Centrella PA, Gondo C, DeLorey JL, Clark MA. Development and synthesis of DNA-encoded benzimidazole library. ACS Combinatorial Science. 2018;20:251-255. DOI: 10.1021/acscombsci.8b00009
  12. 12. El-Gohary NS, Shaaban MI. Synthesis, antimicrobial, antiquorum-sensing and antitumor activities of new benzimidazole analogs. European Journal of Medicinal Chemistry. 2017;137:439-449. DOI: 10.1016/j.ejmech.2017.05.064
  13. 13. Kanwal A, Saddique FA, Aslam S, Ahmad M, Zahoor AF, Moshin NA. Benzimidazole ring system as a privileged template for anticancer agents. Pharmaceutical Chemistry Journal. 2018;51(12):1068-1077. DOI: 10.1007/s11094-018-1742-4
  14. 14. Yadav S, Narasimhan B, Kaur H. Perspectives of benzimidazole derivatives as anticancer agents in the new era. Anti-Cancer Agents in Medicinal Chemistry. 2016;16(11):1403-1425. DOI: 10.2174/1871520616666151103113412
  15. 15. Chaves S, Hiremathad A, Tomas D, Keri RS, Piemontese L, Santos MA. Exploring the chelating capacity of 2-hydroxyphenyl-benzimidazole based hybrids with multi-target ability as anti-Alzheimer’s agent. New Journal of Chemistry. 2018;42(20):16503-16515. DOI: 10.1039/c8nj00117k
  16. 16. Fang Y, Zhou H, Xu J. Synthesis and evaluation of tetrahydroisoquinoline-benzimidazole hybrids as multifunctional agents for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry. 2019;167:133-145. DOI: 10.1016/j.ejmech.2019.02.008
  17. 17. Aboul-Enein HY, Rashedy AAE. Benzimidazole derivatives as antidiabetic agents. Medicinal Chemistry. 2015;5(7):318-325. DOI: 10.4172/2161-0444.1000280
  18. 18. Adegboye AA, Khan KM, Salar U, Aboaba SA, Kanwal CS, Fatima I, et al. 2-Aryl benzimidazoles: Synthesis, in vitro α-amylase inhibitory activity, and molecular docking study. European Journal of Medicinal Chemistry. 2018;150:248-260. DOI: 10.1016/j.ejmech. 2018.03.011
  19. 19. Farahat AA, Ismail MA, Kumar A, Wenzler T, Brun R, Paul A, et al. Indole and benzimidazole bichalcophenes: Synthesis, DNA binding and antiparasitic activity. European Journal of Medicinal Chemistry. 2018;143:1590-1596. DOI: 10.1016/j.ejmech.2017.10.056
  20. 20. Marinescu M, Tudorache GD, Marton GI, Zalaru CM, Popa M, Chifiriuc MC, et al. Density functional theory molecular modeling, chemical synthesis, and antimicrobial behaviour of selected benzimidazole derivatives. Journal of Molecular Structure. 2017;1130:463-471. DOI: 10.1016/j.molstruc.2016. 10.066
  21. 21. Bansal Y, Kaur M, Bansal G. Antimicrobial potential of benzimidazole derived molecules. Mini-Reviews in Medicinal Chemistry. 2019;19(8):624-646. DOI: 10.2174/1389557517666171101104024
  22. 22. Gaba M, Singh S, Mohan C. Benzimidazole: An emerging scaffold for analgesic and anti-inflammatory agents. European Journal of Medicinal Chemistry. 2014;76:494-505. DOI: 10.1016/j.ejmech.2014.01.030
  23. 23. Brown AD, Bagal SK, Blackwell P, Blakemore DC, Brown B, Bungay PJ, et al. The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of pain. European Journal of Medicinal Chemistry. 2019;27:230-239. DOI: 10.1016/j.bmc. 2018.12.002
  24. 24. Pan T, He X, Chen B, Chen H, Gheng G, Luo H, et al. Development of benzimidazole derivatives to inhibit HIV-1 replication through protecting APOBEC3G protein. European Journal of Medicinal Chemistry. 2015;95:500-513. DOI: 10.1016/j.ejmech.2015.03.050
  25. 25. Hameed A, Hameed A, Farooq T, Noreen R, Javed S, Batool S, et al. Evaluation of structurally different benzimidazoles as priming agents, plant defence activators and growth enhancers in wheat. BMC Chemistry. 2019;13(29):1-11. DOI: 10.1186/s13065-019-0546-2
  26. 26. Mamedov VA. Recent advances in the synthesis of benzimidazol(on)esviarearrangements of quinoxalin(on)es. RSC Advances. 2016;6:42132-42172. DOI: 10.1039/C6RA03907C
  27. 27. Cheong JE, Zaffagni M, Chung I, Xu Y, Wang Y, Jernigan FE, et al. Synthesis and anticancer activity of novel water soluble benzimidazole carbamates. European Journal of Medicinal Chemistry. 2018;144:372-385. DOI: 10.1016/j.ejmech.2017.11.037
  28. 28. Bistrovic A, Krstulovic L, Harej A, Grbcic P, Sedic M, Kostrun S, et al. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer. European Journal of Medicinal Chemistry. 2018;143:1616-1634. DOI: 10.1016/j.ejmech.2017.10.061
  29. 29. Si W, Zhang T, Li Y, She D, Pan W, Gao Z, et al. Synthesis and biological activity of novel benzimidazole derivatives as potential antifungal agents. Journal of Pesticide Science. 2016;41(1):15-19. DOI: 10.1584/jpestics.D15-037
  30. 30. Nguyen TV, Peszko MT, Melander RJ, Melander C. Using 2-amino-benzimidazole derivatives to inhibitMycobacterium smegmatisbiofilm formation. MedChemComm. 2019;10(3):456-459. DOI: 10.1039/C9MD00025A
  31. 31. Siddiqui M, Alam MS, Sahu M, Yar MS, Alam O, Siddiqui MJA. Antidepressant, analgesic activity and SAR studies of substituted benzimidazoles. Asian Journal of Pharmaceutical Research. 2016;6(3):170-174. DOI: 10.5958/2231-5691.2016. 00024.1
  32. 32. Tahlan S, Ramasamy K, Lim SM, Shah SAA, Mani V, Narasimhan B. Design, synthesis and therapeutic potential of 3-(2-(1H-benzo[d]imidazol-2-ylthio) acetamido)-N-(substituted phenyl)benzamide analogues. Chemistry Central Journal. 2018;12(139):1-12. DOI: 10.1186/s13065-018-0513-3
  33. 33. Xu M, Wang SL, Zhu L, Wu PY, Dai WB, Rakesh KP. Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review. European Journal of Medicinal Chemistry. 2019;164:448-470. DOI: 10.1016/j.ejmech.2018.12.073
  34. 34. Wright JB. The chemistry of the benzimidazoles. Chemical Reviews. 1951;43(3):397-541. DOI: 10.1021/cr60151a002
  35. 35. Preston PN. Synthesis, reactions, and spectroscopic properties of benzimidazoles. Chemical Reviews. 1974;74(3):279-314. DOI: 10.1021/cr60289a001
  36. 36. Mamedov VA, Khavizova EA, Syakaev VV, Gubaidullin AT, Samigullina AI, Algaeva NE, et al. The rearrangement of 1H, 1’H-spiro[quinoline-4,2′-quinoxaline]-2,3’(3H,4’H)-diones: A new and efficient method for the synthesis of 4-(benzimidazol-2-yl)quinolin-2(1H)-ones. Tetrahedron. 2018;74(45):6544-6557. DOI: 10.1016/j.tet.2018.09.035
  37. 37. Mamedov VA, Zhukova NA, Sinyashin OG. Advances in the synthesis of benzimidazolonesviarearrangements of benzodiazepinones and quinoxalin(on)es. Mendeleev Communications. 2017;27(1):1-11. DOI: 10.1016/j.mencom.2017.01.001
  38. 38. Khose VN, John ME, Pandey AD, Karnik AV. Chiral benzimidazoles and their applications in stereodiscrimination processes. Tetrahedron: Asymmetry. 2017;28(10):1233-1289. DOI: 10.1016/j.tetasy.2017.09.001
  39. 39. Said NR, Mustakim MA, Sani MMM, Baharin SNA. Heck reaction using palladium-benzimidazole catalyst: Synthesis, characterisation and catalytic activity. IOP Conference Series: Materials Science and Engineering. 2018;458(012019):1-7. DOI: 10.1088/1757-899X/458/1/012019
  40. 40. Gunnaz S, Gokce AG, Turkmen H. Synthesis of bimetallic complexes bridged by 2,6-bis(benzimidazol-2-yl) pyridine derivatives and their catalytic properties in transfer hydrogenation. Dalton Transactions. 2018;47:17317-17328. DOI: 10.1039/c8dt03178a
  41. 41. Horak E, Kassal P, Steinberg M. Benzimidazole as a structural unit in fluorescent chemical sensors: The hidden properties of a multifunctional heterocyclic scaffold. Supramolecular Chemistry. 2017;30(10):838-857
  42. 42. Jiang JJ, Pan M, Liu JM, Wang W, Su CY. Assembly of robust and porous hydrogen-bonded coordination frameworks: Isomorphism, polymorphism, and selective adsorption. Inorganic Chemistry. 2010;49(21):10166-10173. DOI: 10.1021/ic1014384
  43. 43. Agarwal RA, Aijaz A, Ahmad M, Sañudo EC, Xu Q , Bharadwaj PK. Two new coordination polymers with Co(II) and Mn(II): Selective gas adsorption and magnetic studies. Crystal Growth & Design. 2012;12(6):2999-3005. DOI: 10.1021/cg300217v
  44. 44. Nath I, Chakraborty J, Verpoort F. Metal organic frameworks mimicking natural enzymes: A structural and functional analogy. Chemical Society Reviews. 2016;45(15):4127-4170. DOI: 10.1039/C6CS00047A
  45. 45. Tan S, Wei B, Liang T, Yang X, Wu Y. Anhydrous proton conduction in liquid crystals containing benzimidazole moieties. RSC Advances. 2016;6(40):34038-34042. DOI: 10.1039/C6RA03375J
  46. 46. Yuan S, Guo X, Aili D, Pan C, Li Q , Fang J. Poly(imidebenzimidazole)s for high temperature polymer electrolyte membrane fuel cells. Journal of Membrane Science. 2014;454(12):351-358. DOI: 10.1016/j.memsci.2013.12.007
  47. 47. Yin C, Dong J, Zhang Z, Zhang Q , Lin J. Structure and properties of polyimide fibers containing benzimidazole and amide units. Journal of Polymer Science. 2015;53:183-191. DOI: 10.1002/polb.23606
  48. 48. Nabavian S, Naderi R, Asadi N. Determination of optimum concentration of benzimidazole improving the cathodic disbonding resistance of epoxy coating. Coatings. 2018;8(12):471. DOI: 10.3390/coatings8120471
  49. 49. HMS I, Bhowmik S, Benedictus R. Performance evaluation of poly-benzimidazole coating for aerospace application. Progress in Organic Coatings. 2017;105:190-199. DOI: 10.1016/j.porgcoat.2017.01.005
  50. 50. Kumar VV, Kumar CR, Suresh A, Jayalakshmi S, Mudali UK, Sivaraman N. Evaluation of polybenzimidazole-based polymers for the removal of uranium, thorium and palladium from aqueous medium. Royal Society Open Science. 2018;5(171701):1-16. DOI: 10.1098/rsos.171701
  51. 51. Mandal S, Gwoen S. Characterizing thermal protective fabrics of firefighters’ clothing in hot surface contact. Journal of Industrial Textiles. 2016;47(5):1-18. DOI: 10.1177/1528083716667258
  52. 52. Akhtar FH, Kumar M, Villalobos LF, Vovusha H, Shevate R, Schwingenschlögl U, et al. Polybenzimidazole-based mixed membranes with exceptional high water vapor permeability and selectivity. Journal of Materials Chemistry A. 2017;5(41):21807-21819. DOI: 10.1039/C7TA05081J
  53. 53. Muthuraja A, Kalainathan S. A study on growth, optical, mechanical, and NLO properties of 2-mercaptobenzimidazole, 2-phenylbenzimidazole and 2-hydroxy benzimidazole single crystals: A comparative investigation. Materials Technology. 2017;32(6):335-348. DOI: 10.1080/10667857.2016.1235080
  54. 54. Tayade RP, Sekar N. Benzimidazole-thiazole based NLOphoric styryl dyes with solid state emission – Synthesis, photophysical, hyperpolarizability and TD-DFT studies. Dyes and Pigments. 2016;128:111-123. DOI: 10.1016/j.dyepig.2016.01.012
  55. 55. Gupta PK. Toxicity of fungicides. In: Gupta RC, editor. Veterinary Toxicology. Basic and Clinical Principles. Hopkinsville, KY: Academic Press; 2018. pp. 569-580. DOI: 10.1016/B978-0-12-811410-0.00045-3
  56. 56. Emler S, Scholze M, Kortenkamp A. Seven benzimidazole pesticides combined at sub-threshold levels induce micronuclei in vitro. Mutagenesis. 2013;28(4):417-426. DOI: 10.1093/mutage/get019
  57. 57. Eldebss TMA, Farag AM, Shamy AYM. Synthesis of some benzimidazole-based heterocycles and their application as copper corrosion inhibitors. Journal of Heterocyclic Chemistry. 2019;56(2):371-390. DOI: 10.1002/jhet.3407
  58. 58. Wang X, Yang H, Wang F. An investigation of benzimidazole derivative as corrosion inhibitor for mild steel in different concentration HCl solutions. Corrosion Science. 2011;53:113-121. DOI: 10.1016/j.corsci.2010.09.029
  59. 59. Saltan GM, Dincalp H, Kiran M, Zafer C, Erbaş SC. Novel organic dyes based on phenyl-substituted benzimidazole for dye sensitized solar cells. Materials Chemistry and Physics. 2015;163:387-393. DOI: 10.1016/j.matchemphys.2015.07.055
  60. 60. Zhao Y, Chao W, Qiu P, Li X, Wang Q , Chen J, et al. New benzimidazole-based bipolar hosts: Highly efficient phosphorescent and thermally activated delayed fluorescent OLEDs employing the same device structure. ACS Applied Materials & Interfaces. 2016;8(4):2635-2643. DOI: 10.1021/acsami.5b10464

Written By

Maria Marinescu

Reviewed: May 31st, 2019 Published: October 2nd, 2019